|
AXGN | Axogen, Inc. |
|
|
AXGN | Axogen, Inc. |
| Electromedical & Electrotherapeutic Apparatus |
| Book value per $ invested | $ 0.16 |
| Leverage | 45.35% |
| Market Cap | $ 722.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -4.7m |
| Margin | -2.30% |
AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida.